Atwood & Palmer’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37 | Hold |
18
| – | – | ﹤0.01% | 507 |
|
|
2025
Q1 | $30 | Hold |
18
| – | – | ﹤0.01% | 435 |
|
|
2024
Q4 | $33 | Hold |
18
| – | – | ﹤0.01% | 464 |
|
|
2024
Q3 | $105 | Hold |
18
| – | – | ﹤0.01% | 466 |
|
|
2024
Q2 | $146 | Hold |
18
| – | – | ﹤0.01% | 426 |
|
|
2024
Q1 | $250 | Sell |
18
-1
| -5% | -$14 | ﹤0.01% | 403 |
|
|
2023
Q4 | $115 | Hold |
19
| – | – | ﹤0.01% | 395 |
|
|
2023
Q3 | $88 | Hold |
19
| – | – | ﹤0.01% | 407 |
|
|
2023
Q2 | $101 | Hold |
19
| – | – | ﹤0.01% | 389 |
|
|
2023
Q1 | $185 | Hold |
19
| – | – | ﹤0.01% | 362 |
|
|
2022
Q4 | $351 | Hold |
19
| – | – | ﹤0.01% | 380 |
|
|
2022
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 384 |
|
|
2022
Q2 | $0 | Hold |
19
| – | – | ﹤0.01% | 420 |
|
|
2022
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 435 |
|
|
2021
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 447 |
|
|
2021
Q3 | $2K | Hold |
19
| – | – | ﹤0.01% | 415 |
|
|
2021
Q2 | $2K | Hold |
19
| – | – | ﹤0.01% | 402 |
|
|
2021
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 425 |
|
|
2020
Q4 | $2K | Hold |
19
| – | – | ﹤0.01% | 355 |
|
|
2020
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 307 |
|
|
2020
Q2 | $6K | Hold |
19
| – | – | ﹤0.01% | 280 |
|
|
2020
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 301 |
|
|
2019
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 288 |
|
|
2019
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 311 |
|
|
2019
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 290 |
|
|
2019
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 318 |
|
|
2018
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 310 |
|
|
2018
Q3 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 305 |
|